BD’s President of Interventional Rick Byrd to Retire

BD (Becton, Dickinson and Company) announced that Richard (Rick) Byrd intends to retire from the company after nearly 25 years with BD.

Byrd is currently executive vice president and president of BD’s Interventional Segment, a role he has served in since September 2022. During his tenure at the company, he held several leadership positions including worldwide president of Medication Delivery Solutions and worldwide president of Preanalytical Systems.

Before joining BD in 2004, Byrd had several leadership and engineering positions in the medical device and advanced technology sectors.

“Over his long career, Rick has led his teams to deliver meaningful results for BD—strengthening our portfolio, elevating our operational rigor and advancing BD’s role as a global healthcare leader,” said Tom Polen, chairman, CEO, and president of BD. “Rick has driven impact across multiple segments, including expanding BD’s leadership in Vascular Access Management, advancing our ‘One‑Stick Hospital Stay’ vision and leading critical manufacturing scale‑up efforts during the COVID-19 pandemic. We thank Rick for his many contributions to BD and wish him all the best in his retirement.”

The company said that Byrd will remain in his role through June. BD plans to name a successor before his retirement date.

“What has inspired me most throughout my time at BD is the people—the teams who show up every day committed to driving the future of care and improving outcomes for patients everywhere,” Byrd said. “I’m incredibly proud of the meaningful work we’ve accomplished together and am confident that BD will continue to deliver on its purpose of advancing the world of health.”